Overview Fundamentals API Earnings EOD API Sample Code Pricing

FibroGen Inc (FGEN MX) stock market data APIs

₱6.4 0(0%) as of October 31, 2024
Price chart is built with Anychart

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of locally advanced pancreatic cancer; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

FibroGen Inc Financial Data Overview

6.4
6.4
-
6.4
6.4
6.33-48
643 M
100 M
174 M
0.702
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'FGEN',
Type: 'Common Stock',
Name: 'FibroGen Inc',
Exchange: 'MX',
CurrencyCode: 'MXN',
CurrencyName: 'Mexican Peso',
CurrencySymbol: '₱',
CountryName: 'Mexico',
CountryISO: 'MX',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

FibroGen Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 174 M
  • EBITDA -165 835 008
  • Earnings Per Share -34.12
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get FibroGen Inc Earnings via APIs

  • Latest Release 2024-11-04
  • EPS/Forecast NaN

Get FibroGen Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com